Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C153 - Neurogenetics: Diagnostic Dilemmas and Therapeutic Implications

Thursday 04/07/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jacinda B. Sampson, MD, PhD
General Neurology
Participants should be able to recognize and manage pediatric and adult neurogenetic diagnostic dilemmas, and become familiar with therapeutic implications and breakthroughs in the field.
2.00 CME credits
Patient Care & Procedural Skills
Introductory
Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:45 AM PDT Speaker Cases (and Lessons) from a Pediatric Neurogenomics Clinic
Maura R.Z. Ruzhnikov, MD
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
Jacinda B. Sampson, MD, PhD
07:45 AM - 08:00 AM PDT Q&A Questions and Answers
Maura R.Z. Ruzhnikov, MD
08:00 AM - 08:45 AM PDT Speaker Adult Cases in Neurogenetics: Dilemmas and Therapeutic Options
Jacinda B. Sampson, MD, PhD
08:45 AM - 09:00 AM PDT Q&A Questions and Answers
Jacinda B. Sampson, MD, PhD
Faculty Disclosures
Jacinda B. Sampson, MD, PhD Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Maura R.Z. Ruzhnikov, MD Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere Therapeutics. Dr. Ruzhnikov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapetuics. The institution of Dr. Ruzhnikov has received research support from Grace Science Foundation. The institution of Dr. Ruzhnikov has received research support from Ionis Pharmaceuticals. The institution of Dr. Ruzhnikov has received research support from NIH. Dr. Ruzhnikov has a non-compensated relationship as a Co-founder and Secretary with Little Zebra Fund that is relevant to AAN interests or activities.